Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy
- PMID: 26104026
- DOI: 10.1111/iju.12856
Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy
Comment on
-
High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy.Int J Urol. 2015 Sep;22(9):827-33. doi: 10.1111/iju.12839. Epub 2015 Jun 18. Int J Urol. 2015. PMID: 26087772
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources